Systematic Analysis of CA9 as a Pan-Cancer Marker for Prognosis and Immunity
This study provides compelling evidence that CA9 is a potential pan-cancer prognostic marker and diagnostic tool. The associations of CA9 with immune components and determinants of immunotherapy response indicate the importance of CA9 in advancing cancer research and personalized treatment strategies.
Authors
- Yide Mei (ORCID: https://orcid.org/0000-0002-8670-7394)
- Zhu Yang (ORCID: https://orcid.org/0000-0002-0610-499X)
- Qiang Yi (ORCID: https://orcid.org/0009-0003-3188-665X)
- Yi Liu (ORCID: https://orcid.org/0009-0009-1151-4297)
Institutions
- Dalian Medical University (CN)
- Second Affiliated Hospital of Chongqing Medical University (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Cancer Informatics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1177/11769351251380520
- Citations
- 1
- Primary Topic
- Enzyme function and inhibition
- Type
- article
- Field-Weighted Citation Impact
- 0.81